series-c-plus
Stage
1
Investors
About
therapies for hematological malignancies and disorders
Explore Biosight's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
therapies for hematological malignancies and disorders
Funding rounds, investor list, and risk signals — unlock with a subscription.